Loading…

Treatment of the Pregnant Patient with Inflammatory Bowel Disease

Research regarding fertility, medication safety, and pregnancy outcomes is increasing, but there are still many knowledge gaps in these areas. Women with ulcerative colitis and Crohn's disease may have decreased fertility because of voluntary childlessness and inflammatory bowel disease (IBD) s...

Full description

Saved in:
Bibliographic Details
Published in:Inflammatory bowel diseases 2016-03, Vol.22 (3), p.733-744
Main Authors: Winter, Rachel, Nørgård, Bente M, Friedman, Sonia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c353t-adbe324eb178325712ad20a916b4d5e68934263e0d6708bc8a9fa106cb83202e3
cites cdi_FETCH-LOGICAL-c353t-adbe324eb178325712ad20a916b4d5e68934263e0d6708bc8a9fa106cb83202e3
container_end_page 744
container_issue 3
container_start_page 733
container_title Inflammatory bowel diseases
container_volume 22
creator Winter, Rachel
Nørgård, Bente M
Friedman, Sonia
description Research regarding fertility, medication safety, and pregnancy outcomes is increasing, but there are still many knowledge gaps in these areas. Women with ulcerative colitis and Crohn's disease may have decreased fertility because of voluntary childlessness and inflammatory bowel disease (IBD) surgery, and women with Crohn's disease may also have decreased ovarian reserve. Initial studies show that in vitro fertilization is a viable option, and laparoscopic ileoanal pouch anastomosis surgery improves fertility rates. Additional research is needed on the effect of disease activity on fertility and on the rates of pregnancy loss and ectopic pregnancies. We do not know how to reliably measure disease activity during pregnancy or the effect of pregnancy on the microbiome. Although immunomodulators and anti-tumor necrosis factor medications are relatively safe during pregnancy, the long-term effects of these medications on the child are unknown. The recommended mode of delivery is still debated, especially for women after ileoanal pouch anastomosis. There are multiple studies on the relative safety of immunomodulators and anti-tumor necrosis factor medications during pregnancy, and we know how to safely treat a pregnant patient with a disease flare. The best way to manage women with IBD who are pregnant or contemplating pregnancy is a multidisciplinary approach. Team members often include a gastroenterologist, a high-risk obstetrician, an infertility specialist, a colorectal surgeon, and a pediatrician with experience in caring for children of mothers with IBD. By integrating expertise from these disciplines, women with even very complex IBD should be able to have a healthy pregnancy and delivery.
doi_str_mv 10.1097/MIB.0000000000000625
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1765110686</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1765110686</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-adbe324eb178325712ad20a916b4d5e68934263e0d6708bc8a9fa106cb83202e3</originalsourceid><addsrcrecordid>eNpdkMlOwzAQhi0EoqXwBgjlyCXFe-xjW7ZKRfRQzpaTTGhQlmK7qvr2uCogxMxhFv3_jPQhdE3wmGCd3b3Mp2P8NyQVJ2hIBJMpV5yfxh5nKsVaqwG68P4DYxpTn6MBlVIoSuQQTVYObGihC0lfJWENydLBe2fjvLShPux3dVgn865qbNva0Lt9Mu130CT3tQfr4RKdVbbxcPVdR-jt8WE1e04Xr0_z2WSRFkywkNoyB0Y55CRTjIqMUFtSbDWROS8FSKUZp5IBLmWGVV4oqytLsCzyKMcU2AjdHu9uXP-5BR9MW_sCmsZ20G-9IZkUJBqUjFJ-lBau995BZTaubq3bG4LNAZ6J8Mx_eNF28_1hm7dQ_pp-aLEvOURosA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1765110686</pqid></control><display><type>article</type><title>Treatment of the Pregnant Patient with Inflammatory Bowel Disease</title><source>Oxford Journals Online</source><creator>Winter, Rachel ; Nørgård, Bente M ; Friedman, Sonia</creator><creatorcontrib>Winter, Rachel ; Nørgård, Bente M ; Friedman, Sonia</creatorcontrib><description>Research regarding fertility, medication safety, and pregnancy outcomes is increasing, but there are still many knowledge gaps in these areas. Women with ulcerative colitis and Crohn's disease may have decreased fertility because of voluntary childlessness and inflammatory bowel disease (IBD) surgery, and women with Crohn's disease may also have decreased ovarian reserve. Initial studies show that in vitro fertilization is a viable option, and laparoscopic ileoanal pouch anastomosis surgery improves fertility rates. Additional research is needed on the effect of disease activity on fertility and on the rates of pregnancy loss and ectopic pregnancies. We do not know how to reliably measure disease activity during pregnancy or the effect of pregnancy on the microbiome. Although immunomodulators and anti-tumor necrosis factor medications are relatively safe during pregnancy, the long-term effects of these medications on the child are unknown. The recommended mode of delivery is still debated, especially for women after ileoanal pouch anastomosis. There are multiple studies on the relative safety of immunomodulators and anti-tumor necrosis factor medications during pregnancy, and we know how to safely treat a pregnant patient with a disease flare. The best way to manage women with IBD who are pregnant or contemplating pregnancy is a multidisciplinary approach. Team members often include a gastroenterologist, a high-risk obstetrician, an infertility specialist, a colorectal surgeon, and a pediatrician with experience in caring for children of mothers with IBD. By integrating expertise from these disciplines, women with even very complex IBD should be able to have a healthy pregnancy and delivery.</description><identifier>ISSN: 1078-0998</identifier><identifier>EISSN: 1536-4844</identifier><identifier>DOI: 10.1097/MIB.0000000000000625</identifier><identifier>PMID: 26658216</identifier><language>eng</language><publisher>England</publisher><subject>Abnormalities, Drug-Induced - prevention &amp; control ; Female ; Humans ; Immunosuppressive Agents - therapeutic use ; Inflammatory Bowel Diseases - drug therapy ; Pregnancy ; Pregnancy Complications - drug therapy ; Pregnancy Outcome</subject><ispartof>Inflammatory bowel diseases, 2016-03, Vol.22 (3), p.733-744</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-adbe324eb178325712ad20a916b4d5e68934263e0d6708bc8a9fa106cb83202e3</citedby><cites>FETCH-LOGICAL-c353t-adbe324eb178325712ad20a916b4d5e68934263e0d6708bc8a9fa106cb83202e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26658216$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Winter, Rachel</creatorcontrib><creatorcontrib>Nørgård, Bente M</creatorcontrib><creatorcontrib>Friedman, Sonia</creatorcontrib><title>Treatment of the Pregnant Patient with Inflammatory Bowel Disease</title><title>Inflammatory bowel diseases</title><addtitle>Inflamm Bowel Dis</addtitle><description>Research regarding fertility, medication safety, and pregnancy outcomes is increasing, but there are still many knowledge gaps in these areas. Women with ulcerative colitis and Crohn's disease may have decreased fertility because of voluntary childlessness and inflammatory bowel disease (IBD) surgery, and women with Crohn's disease may also have decreased ovarian reserve. Initial studies show that in vitro fertilization is a viable option, and laparoscopic ileoanal pouch anastomosis surgery improves fertility rates. Additional research is needed on the effect of disease activity on fertility and on the rates of pregnancy loss and ectopic pregnancies. We do not know how to reliably measure disease activity during pregnancy or the effect of pregnancy on the microbiome. Although immunomodulators and anti-tumor necrosis factor medications are relatively safe during pregnancy, the long-term effects of these medications on the child are unknown. The recommended mode of delivery is still debated, especially for women after ileoanal pouch anastomosis. There are multiple studies on the relative safety of immunomodulators and anti-tumor necrosis factor medications during pregnancy, and we know how to safely treat a pregnant patient with a disease flare. The best way to manage women with IBD who are pregnant or contemplating pregnancy is a multidisciplinary approach. Team members often include a gastroenterologist, a high-risk obstetrician, an infertility specialist, a colorectal surgeon, and a pediatrician with experience in caring for children of mothers with IBD. By integrating expertise from these disciplines, women with even very complex IBD should be able to have a healthy pregnancy and delivery.</description><subject>Abnormalities, Drug-Induced - prevention &amp; control</subject><subject>Female</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Inflammatory Bowel Diseases - drug therapy</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - drug therapy</subject><subject>Pregnancy Outcome</subject><issn>1078-0998</issn><issn>1536-4844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpdkMlOwzAQhi0EoqXwBgjlyCXFe-xjW7ZKRfRQzpaTTGhQlmK7qvr2uCogxMxhFv3_jPQhdE3wmGCd3b3Mp2P8NyQVJ2hIBJMpV5yfxh5nKsVaqwG68P4DYxpTn6MBlVIoSuQQTVYObGihC0lfJWENydLBe2fjvLShPux3dVgn865qbNva0Lt9Mu130CT3tQfr4RKdVbbxcPVdR-jt8WE1e04Xr0_z2WSRFkywkNoyB0Y55CRTjIqMUFtSbDWROS8FSKUZp5IBLmWGVV4oqytLsCzyKMcU2AjdHu9uXP-5BR9MW_sCmsZ20G-9IZkUJBqUjFJ-lBau995BZTaubq3bG4LNAZ6J8Mx_eNF28_1hm7dQ_pp-aLEvOURosA</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Winter, Rachel</creator><creator>Nørgård, Bente M</creator><creator>Friedman, Sonia</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201603</creationdate><title>Treatment of the Pregnant Patient with Inflammatory Bowel Disease</title><author>Winter, Rachel ; Nørgård, Bente M ; Friedman, Sonia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-adbe324eb178325712ad20a916b4d5e68934263e0d6708bc8a9fa106cb83202e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Abnormalities, Drug-Induced - prevention &amp; control</topic><topic>Female</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Inflammatory Bowel Diseases - drug therapy</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - drug therapy</topic><topic>Pregnancy Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Winter, Rachel</creatorcontrib><creatorcontrib>Nørgård, Bente M</creatorcontrib><creatorcontrib>Friedman, Sonia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Inflammatory bowel diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Winter, Rachel</au><au>Nørgård, Bente M</au><au>Friedman, Sonia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of the Pregnant Patient with Inflammatory Bowel Disease</atitle><jtitle>Inflammatory bowel diseases</jtitle><addtitle>Inflamm Bowel Dis</addtitle><date>2016-03</date><risdate>2016</risdate><volume>22</volume><issue>3</issue><spage>733</spage><epage>744</epage><pages>733-744</pages><issn>1078-0998</issn><eissn>1536-4844</eissn><abstract>Research regarding fertility, medication safety, and pregnancy outcomes is increasing, but there are still many knowledge gaps in these areas. Women with ulcerative colitis and Crohn's disease may have decreased fertility because of voluntary childlessness and inflammatory bowel disease (IBD) surgery, and women with Crohn's disease may also have decreased ovarian reserve. Initial studies show that in vitro fertilization is a viable option, and laparoscopic ileoanal pouch anastomosis surgery improves fertility rates. Additional research is needed on the effect of disease activity on fertility and on the rates of pregnancy loss and ectopic pregnancies. We do not know how to reliably measure disease activity during pregnancy or the effect of pregnancy on the microbiome. Although immunomodulators and anti-tumor necrosis factor medications are relatively safe during pregnancy, the long-term effects of these medications on the child are unknown. The recommended mode of delivery is still debated, especially for women after ileoanal pouch anastomosis. There are multiple studies on the relative safety of immunomodulators and anti-tumor necrosis factor medications during pregnancy, and we know how to safely treat a pregnant patient with a disease flare. The best way to manage women with IBD who are pregnant or contemplating pregnancy is a multidisciplinary approach. Team members often include a gastroenterologist, a high-risk obstetrician, an infertility specialist, a colorectal surgeon, and a pediatrician with experience in caring for children of mothers with IBD. By integrating expertise from these disciplines, women with even very complex IBD should be able to have a healthy pregnancy and delivery.</abstract><cop>England</cop><pmid>26658216</pmid><doi>10.1097/MIB.0000000000000625</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1078-0998
ispartof Inflammatory bowel diseases, 2016-03, Vol.22 (3), p.733-744
issn 1078-0998
1536-4844
language eng
recordid cdi_proquest_miscellaneous_1765110686
source Oxford Journals Online
subjects Abnormalities, Drug-Induced - prevention & control
Female
Humans
Immunosuppressive Agents - therapeutic use
Inflammatory Bowel Diseases - drug therapy
Pregnancy
Pregnancy Complications - drug therapy
Pregnancy Outcome
title Treatment of the Pregnant Patient with Inflammatory Bowel Disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T18%3A13%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20the%20Pregnant%20Patient%20with%20Inflammatory%20Bowel%20Disease&rft.jtitle=Inflammatory%20bowel%20diseases&rft.au=Winter,%20Rachel&rft.date=2016-03&rft.volume=22&rft.issue=3&rft.spage=733&rft.epage=744&rft.pages=733-744&rft.issn=1078-0998&rft.eissn=1536-4844&rft_id=info:doi/10.1097/MIB.0000000000000625&rft_dat=%3Cproquest_cross%3E1765110686%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-adbe324eb178325712ad20a916b4d5e68934263e0d6708bc8a9fa106cb83202e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1765110686&rft_id=info:pmid/26658216&rfr_iscdi=true